Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia (Q27824808)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia
scientific article

    Statements

    title
    Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia (English)
    1 reference
    stated in
    PubMed
    PubMed ID
    14726387
    retrieved
    13 November 2016
    author
    Hagop Kantarjian
    series ordinal
    5
    object named as
    Hagop Kantarjian
    0 references
    Francis Giles
    series ordinal
    4
    object named as
    Francis Giles
    0 references
    author name string
    B Douglas Smith
    series ordinal
    1
    0 references
    Mark Levis
    series ordinal
    2
    0 references
    Miloslav Beran
    series ordinal
    3
    0 references
    Karin Berg
    series ordinal
    6
    0 references
    Kathleen M Murphy
    series ordinal
    7
    0 references
    Tianna Dauses
    series ordinal
    8
    0 references
    Jeffrey Allebach
    series ordinal
    9
    0 references
    Donald Small
    series ordinal
    10
    0 references
    publication date
    15 May 2004
    0 references
    published in
    Blood
    0 references
    volume
    103
    0 references
    issue
    10
    0 references
    page(s)
    3669-76
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q27824808&oldid=1521305634"